| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50a09e48366aa06b1a5cddf4a655fc7b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2009-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9387a7c207bcff20ee5640e5a72c1eaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04d08d25f4ab81ecd3d8d3ca4a0b12d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bd57e67dcac3be7b26f00b2d33159a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_305291bb8433eede996a9cba6e875965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f23a47bfa1aeaf4be8f3e35047ab80ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdc1ebd5c7b22e3a5da3253d7fb5d7e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1781a8369676384aa3949d208d5a9733
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25eb258198ce8fab20a3fda03af1fb3a |
| publicationDate |
2014-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2009234389-B2 |
| titleOfInvention |
Compositions and methods for detecting EGFR mutations in cancer |
| abstract |
The invention discloses binding agents to the E746 - A750 deletion and the L858R point mutations in the epidermal growth factor receptor (EGFR) molecule, and methods for use thereof, including methods for the diagnosis and treatment of cancer. |
| priorityDate |
2008-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |